White Paper
"Resource allocation in Life Science multinationals“
How to effectively allocate funds across businesses and functions
With a more moderate business outlook of 3-6 percent average growth over the next five years and increasing pressure on margins, an “old friend” has again found its way into corporate offices of the Life Science industry: Zero-Based Budgeting. What at first glance appears to be a modern planning technique to challenge cost budgets, often turns out to be a one-time exercise without any sustainable effect on profitability. Yet what are the alternatives?
Kolb, S. / von der Goltz, E.
Erschienen in: White Paper, 2020
Hier geht's zum White Paper!
